首页> 外文期刊>海南医科大学学报(英文版) >Clinical study on the effect of simvastatin on the bone healing in elderly patients with femoral intertrochanteric fracture merged with type 2 diabetes mellitus
【24h】

Clinical study on the effect of simvastatin on the bone healing in elderly patients with femoral intertrochanteric fracture merged with type 2 diabetes mellitus

机译:辛伐他汀对老年股骨转子间骨折合并2型糖尿病患者骨愈合的临床研究

获取原文
获取原文并翻译 | 示例
       

摘要

Objective:To explore the effect of simvastatin on the bone mineral density (BMD) and bone metabolism in elderly patients with femoral intertrochanteric fracture merged with type 2 diabetes mellitus (T2DM).Methods: A total of 120 patients with femoral intertrochanteric fracture merged with T2DM who were admitted in our hospital from June, 2014 to October, 2016 were included in the study and randomized into the observation group and the control group (n=60). The patients in the two groups were given minimally invasive PFNA, and blood sugar and blood pressure reducing. The patients in the control group were given alendronate sodium, 70 mg/time, 1 time/week. On this basis, the patients in the observation group were given simvastatin, 40 mg/time,1 time/every night. After 6-month treatment, the efficacy was evaluated. The morning fasting peripheral venous blood before and after treatment in the two groups was collected. The full automatic biochemical analyzer was used to detect the serum Ca, P, and GHb. ECLI was used to detect the serum OC and BAP. ELISA was used to detect the serum TRACP-5b and s-CTX. The dual energy X-ray absorptiomery was used to detect BMD level of the forearm, femoral neck, and anterial position of lumbar spine.Results:Ca, P, and GHb levels after treatment in the two groups were not significantly changed (P>0.05). BMD level of the forearm, femoral neck, and anterial position of lumbar spine after treatment in the observation group was significantly higher than that in the control group (P<0.05). OC and BAP levels after treatment in the observation group were significantly higher than those in the control group (P<0.05), while s-CTX and TRACP-5b levels were significantly lower than those in the control group (P<0.05).Conclusions:Simvastatin can significantly improve the bone metabolism abnormality in elderly patients with femoral intertrochanteric fracture merged with T2DM, enhance BMD, and promote the bone formation and fracture healing; therefore, it deserves to be widely recommended in the clinic.
机译:目的:探讨辛伐他汀对老年股骨转子间骨折合并2型糖尿病患者的骨密度和骨代谢的影响。方法:共120例股骨转子间骨折合并T2DM患者。研究纳入2014年6月至2016年10月在我院收治的患者,随机分为观察组和对照组(n = 60)。两组患者均接受微创PFNA治疗,血糖和血压降低。对照组患者给予阿仑膦酸钠70 mg /次,每周1次。在此基础上,观察组患者给予辛伐他汀40 mg /次,每晚1次。治疗6个月后,评估疗效。两组均于治疗前后清晨空腹抽取外周静脉血。全自动生化分析仪用于检测血清Ca,P和GHb。 ECLI用于检测血清OC和BAP。 ELISA用于检测血清TRACP-5b和s-CTX。双能X线吸收仪检测前臂,股骨颈和腰椎前位的BMD水平。结果:两组治疗后Ca,P和GHb水平无明显变化(P> 0.05) )。观察组治疗后前臂,股骨颈和腰椎的BMD水平明显高于对照组(P <0.05)。观察组治疗后OC和BAP水平明显高于对照组(P <0.05),而s-CTX和TRACP-5b水平明显低于对照组(P <0.05)。 :辛伐他汀可以显着改善老年股骨转子间骨折合并T2DM的患者的骨代谢异常,增强BMD,促进骨形成和骨折愈合;因此,值得在临床上广泛推荐。

著录项

  • 来源
    《海南医科大学学报(英文版)》 |2017年第5期|79-82|共4页
  • 作者

    Long Zhang; Xiao-Ying Wu;

  • 作者单位

    Department of Orthopedics, The Second Hospital Affiliated to Hebei North University, Zhangjiakou 075100, China;

    Department of Orthopedics, The Second Hospital Affiliated to Hebei North University, Zhangjiakou 075100, China;

  • 收录信息
  • 原文格式 PDF
  • 正文语种 eng
  • 中图分类
  • 关键词

获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号